Patient-derived Cells

Patient-derived cells are living cells collected from an individual and maintained or studied in the laboratory to represent that person’s biology. Researchers isolate cells from tissues or clinical samples, then culture, expand, differentiate, or reprogram them under controlled conditions while preserving relevant genetic and cellular features. These models support investigation of disease mechanisms, cellular responses, and variation between individuals. In biology and biomedical research, patient-derived cells can improve disease modeling and help evaluate potential treatments, although their behavior may change during culture and careful characterization is essential for reliable interpretation.

Patient-derived Cells - Related Videos

Research

JoVE Journal - Cancer Research

In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)

0 Views •

2025

This protocol describes in ovo xenografting of patient-derived B- and T-acute lymphoblastic leukemia (ALL) cells, which occurs 4 days following injection.

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma

0 Views •

Cited by 22 •

2013

This article describes the preparation of freshly obtained melanoma tissue into primary cell cultures, and how to remove contaminations of erythrocytes and fibroblasts from the tumor cells. Finally, we describe how CD133+ putative melanoma stem cells are sorted from the CD133- bulk using Magnetic Activated Cell Sorting (MACS).

Isolation and Immortalization of Patient-derived Cell Lines from Muscle Biopsy for Disease Modeling

0 Views •

Cited by 19 •

2015

This protocol describes techniques for live cell isolation and primary culture of myogenic and fibroblast cell lines from muscle or skin tissue. A technique for the immortalization of these cell lines is also described. Altogether, these protocols provide a reliable tool to generate and preserve patient-derived cells for downstream applications.

Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells

0 Views •

Cited by 59 •

2015

This manuscript details a method used to generate prostate cancer patient derived xenografts (PDXs) from circulating tumor cells (CTCs). The generation of PDX models from CTCs provides an alternative experimental model to study prostate cancer; the most commonly diagnosed tumor and a frequent cause of death from cancer in men.

Zebrafish Patient-Derived Xenograft (zPDX): A Cancer Model

0 Views •

2023

This video describes the technique to create a zebrafish patient derived xenograft model. In the sample protocol, we assess the efficiency of the drugs Gemcitabine and Navitoclax on the pancreatic tumor xenograft model.

View All Results

FAQs

Related Topics